Alpha Crest Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$27.79 - $50.61 $534,262 - $972,977	19,225 New	19,225 $677,000
Q4 2021 Feb 09, 2022	SELL	$58.09 - $82.51 $1.07 Million - $1.52 Million	-18,476 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$58.38 - $84.96 $249,516 - $363,119	-4,274 Reduced 18.79%	18,476 $1.15 Million
Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $1.41 Million - $2.05 Million	22,750 New	22,750 $1.88 Million
Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $226,995 - $334,739	-3,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $162,134 - $315,869	3,700 New	3,700 $284,000
Q2 2019 Aug 12, 2019	SELL	$17.43 - $28.82 $643,167 - $1.06 Million	-36,900 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$12.05 - $20.18 $444,645 - $744,642	36,900 New	36,900 $677,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.